drugset / Trial / NCT05984251
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants
RandomizedSequentialDouble-blindBasic science
Summary
The primary objective of this study will be to evaluate the safety and tolerability of single and multiple oral doses of CCX168, over a range of dose levels, in healthy male and female participants.
Timeline
- Start
- 2009-12-21
- Primary completion
- 2010-09-19
- Completion
- 2011-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avacopan | Small molecule | 1 mg | Oral |
| Subject | Avacopan | Small molecule | 3 mg | Oral |
| Subject | Avacopan | Small molecule | 10 mg | Oral |
| Subject | Avacopan | Small molecule | 30 mg | Oral |
| Subject | Avacopan | Small molecule | 100 mg | Oral |